Morgan Stanley Comments On TMO

Morgan Stanley has issued a report commenting on the start of the year for Thermo Fisher Scientific TMO. In the report Morgan Stanley writes, "Against a challenging basis of comparison and amid concern about the quarter, 1Q showed solid operating performance with organic growth 100bps better than expectations and EPS upside driven by accelerating capital deployment on repurchases." TMO is Overweight rated and closed at $58.08 yesterday.